Earnings release
Page 1
RNS Number : 4242UTate & Lyle PLC26 February 2026 26 February 2026 - Tate & Lyle PLC Q3 trading in line with expectations; outlook for the full-year unchanged;focused on actions to drive top-line growth Tate & Lyle issues the following trading statement for the nine months ended 31 December 2025. Nick Hampton, Chief Executive said:"Tate & Lyle's third quarter operating performance was in line with our expectations and consistent with thefirst half. In November, at our interim results, we outlined a series of actions to drive top-line growth and improveperformance. We made good progress on these actions during the quarter. We continued to make targetedinvestments in capabilities and technology to strengthen our customer offering, and saw further encouragingmomentum in customer engagement in our combined portfolio. The value of cross-selling opportunities in thenew business pipeline increased significantly in the third quarter. Delivering the benefits of the CP Kelco combination continues to progress well with run-rate cost synergies andrevenue synergies tracking in line with our expectations. Our 5-year US$200m productivity programme remainson-track with further savings delivered during the quarter. The renewal of customer framework agreements for the 2026 calendar year is well-advanced. With our numberone priority returning the business to top-line growth, we have selectively chosen to invest to drive volume* andrevenue growth. This is the right thing to do for the business, giving us a stronger platform for future growthand we are pleased with the engagement we are seeing from customers to our expanded offering. In the near term, I am confident that the actions we are taking will improve the top-line performance of thebusiness. Looking further ahead, our leading positions in sweetening, mouthfeel and fortification put us in astrong position to benefit from consumer demand for healthier, more nutritious food and drink. The breadth ofour portfolio coupled with the targeted investments we are making to accelerate customer wins in key growthareas position us well to drive profitable revenue growth over time." TradingFor the three months to 31 December 2025, Group revenue was 15% higher on a reported basis and in constantcurrency, reflecting the combination with CP Kelco on 15 November 2024. On a pro forma basis and in constantcurrency, revenue was 2% lower reflecting continued muted market demand. Performance in all regions wasbroadly in line with the first half. For the nine months to 31 December 2025, on a pro forma basis revenue in the Americas was 2% lower than theprior period, with modestly higher pricing more than offset by lower volume*. In Europe, Middle East and Africalower pricing resulted in 5% lower revenue, while in Asia Pacific revenue was up 1%, driven by higher volume*. Financial results 9 months to31 December 2025 Revenue £m Revenuechange reported1 % RevenueChange pro forma2 % Americas 749 18% (2)% Europe, Middle East and Africa 475 27% (5)% Asia Pacific 282 79% 1% Group 1 506 29% (3)% 1 Comparative information is on a statutory basis, including CP Kelco from acquisition on 15 November 2024. Change is in constant currency. 2 Comparative information is pro forma basis, including the impact of CP Kelco for the entire period. CP Kelco acquisition completed 15 November 2024.Change is in constant currency. Outlook Our outlook for the 2026 financial year is unchanged from our interim results statement on 6 November 2025. For the year ending 31 March 2026, in constant currency and compared to pro forma comparatives, we continueto expect revenue and EBITDA to decline by low-single digit percent compared to the prior year. * Volume is the change in revenue in the period attributable to both the change in volume and the change in composition or mix of revenue.
Page 2
END